[October 14, 2016]

Global Age-related Macular Degeneration Market Growth of 7.37% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Vendors: Bayer Healthcare, Novartis, Alcon - Research and Markets

Research and Markets has announced the addition of the "Global Age-related Macular Degeneration Market 2016-2020" report to their offering.

The report forecasts the global age-related macular degeneration (AMD (News - Alert)) market to grow at a CAGR of 7.37% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global age-related macular degeneration (AMD) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of AMD.

The report, Global Age-Related Macular Degeneration (AMD) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts.

Questions Answered:

• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the strengths and weaknesses of the ke vendors?

• Bayer HealthCare
• F. Hoffmann-La Roche
• Novartis
• Regeneron Pharmaceuticals
• Alcon
• Allergan
• Adverum Biotechnologies
• Bausch + Lomb
• Gilead Sciences
• Iconic Therapeutics
• Lpath
• Neurotech Pharmaceuticals
• Ohr Pharmaceutical
• Opthea
• Ophthotech
• PanOptica
• Pfizer
• Promedior
• QLT
• Quark
• Resolvyx Pharmaceuticals
• RXi Pharmaceuticals
• Sagent Pharmaceuticals
• Santen Pharmaceuticals
• Sanwa Kagaku Kenkyusho
  

Report Structure:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Key buying criteria

PART 06: AMD: Overview

PART 07: Pipeline portfolio

PART 08: Market landscape

PART 09: Market analysis of major drugs

PART 10: Market segmentation by type

PART 11: Market segmentation by ROA

PART 12: Geographical segmentation

PART 13: Market drivers

PART 14: Impact of drivers

PART 15: Market challenges

PART 16: Impact of drivers and challenges

PART 17: Market trends

PART 18: Vendor landscape

PART 19: Key vendor analysis

PART 20: Appendix

PART 21: About the Author

For more information about this report visit http://www.researchandmarkets.com/research/mxr878/global

View source version on businesswire.com: http://www.businesswire.com/news/home/20161014005200/en/

[ Back To TMCnet.com's Homepage ]